Is XMAR or JNJ a better dividend investment in 2026?

XMAR currently yields 4.94% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: XMAR offers higher current income.

What is the dividend yield difference between XMAR and JNJ?

XMAR has a forward dividend yield of 4.94% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1.58 percentage points.

Home › Compare › XMAR vs JNJ

XMAR vs JNJ: Dividend Comparison 2026

XMAR yields 4.94% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XMAR wins by $7.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

XMAR

● Live price

4.94%

Share price

$40.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.7K

Annual income

$677.54

Full XMAR calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — XMAR vs JNJ

📍 XMAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XMAR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XMAR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XMAR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XMAR

Annual income on $10K today (after 15% tax)

$419.86/yr

After 10yr DRIP, annual income (after tax)

$575.91/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $127.70/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XMAR + JNJ for your $10,000?

XMAR: 50%JNJ: 50%

100% JNJ50/50100% XMAR

Portfolio after 10yr

$23.8K

Annual income

$752.66/yr

Blended yield

3.16%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XMAR

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XMAR buys

JNJ buys

No recent congressional trades found for XMAR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXMARJNJ

Forward yield	4.94% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$27.7K ✓	$20.0K
Annual income after 10y	$677.54	$827.78 ✓
Total dividends collected	$5.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: XMAR vs JNJ ($10,000, DRIP)

Year	XMAR Portfolio	XMAR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,194	$493.95	$10,676	$355.77	+$518.00 → XMAR
2	$12,494	$516.75	$11,407	$389.39	+$1.1K → XMAR
3	$13,908	$539.05	$12,198	$426.53	+$1.7K → XMAR
4	$15,442	$560.78	$13,056	$467.62	+$2.4K → XMAR
5	$17,105	$581.91	$13,987	$513.12	+$3.1K → XMAR
6	$18,905	$602.41	$14,998	$563.56	+$3.9K → XMAR
7	$20,850	$622.23	$16,098	$619.52	+$4.8K → XMAR
8	$22,951	$641.37	$17,295	$681.69	+$5.7K → XMAR
9	$25,218	$659.81	$18,599	$750.82	+$6.6K → XMAR
10	$27,661	$677.54	$20,022	$827.78	+$7.6K → XMAR

XMAR vs JNJ: Complete Analysis 2026

XMAR — Stock

The investment objective of the FT Vest U.S. Equity Enhance & Moderate Buffer ETF - March (the "Fund") is to seek to provide investors with returns (before fees and expenses) of approximately twice any positive price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 10.48% while providing a buffer (before fees and expenses) against the first 15% of Underlying ETF losses, over the period from March 24, 2025 through March 20, 2026.

Full XMAR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this XMAR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XMAR vs SCHD XMAR vs JEPI XMAR vs O XMAR vs KO XMAR vs MAIN XMAR vs ABBV XMAR vs MRK XMAR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.